athenahealth, Inc (NASDAQ:ATHN) gets downgraded to Market Perform by Wells Fargo & Co with a price target of $135.00

0

Analyst Ratings For athenahealth, Inc (NASDAQ:ATHN)

Today, athenahealth, Inc (NASDAQ:ATHN) stock was downgraded by Wells Fargo & Co from Outperform to Market Perform with a price target of $135.00.

There are 18 Hold Ratings, 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on athenahealth, Inc (NASDAQ:ATHN) is Hold with a consensus target price of $148.35 per share, a potential 12.01% upside.

Some recent analyst ratings include

  • 11/27/2018-athenahealth, Inc (NASDAQ:ATHN) gets downgraded to Market Perform by Wells Fargo & Co with a price target of $135.00
  • 11/13/2018-athenahealth, Inc (NASDAQ:ATHN) gets downgraded to Hold by SunTrust Banks with a price target of $135.00
  • 11/12/2018-athenahealth, Inc (NASDAQ:ATHN) gets downgraded to Neutral by Piper Jaffray Companies


  • On 10/26/2018 Jonathan D. Porter, SVP, sold 150 with an average share price of $118.33 per share and the total transaction amounting to $17,749.50.
  • On 10/1/2018 Daniel P Haley, Insider, sold 2,204 with an average share price of $127.23 per share and the total transaction amounting to $280,414.92.
  • On 9/26/2018 Jonathan D. Porter, SVP, sold 150 with an average share price of $131.51 per share and the total transaction amounting to $19,726.50.
  • On 8/27/2018 Jonathan D. Porter, SVP, sold 150 with an average share price of $152.53 per share and the total transaction amounting to $22,879.50.
  • On 7/26/2018 Jonathan D. Porter, SVP, sold 150 with an average share price of $146.79 per share and the total transaction amounting to $22,018.50.
  • On 6/26/2018 Jonathan D. Porter, SVP, sold 150 with an average share price of $158.15 per share and the total transaction amounting to $23,722.50.
  • On 6/1/2018 Jonathan Bush, CEO, sold 5,000 with an average share price of $150.32 per share and the total transaction amounting to $751,600.00.

About athenahealth, Inc (NASDAQ:ATHN)
athenahealth, Inc., together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services. The company also provides athenahealth Population Health, a cloud-based population health service; and Epocrates services that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, and market research. In addition, it offers athenahealth Health Plan data exchange facilitates to exchange the data between providers and health plans for the healthcare operations of clients; athenaOne Analytics that includes an analytics and dashboard application, as well as provides visibility into the financial and operational health of an organization; and pre-certification processing and referral processing services. The company serves healthcare providers, medical groups, and health systems through its direct sales force and channel partners in the United States and internationally. athenahealth, Inc. was formerly known as athenahealth.com, Inc. and changed its name to athenahealth, Inc. in November 2000. The company was founded in 1997 and is headquartered in Watertown, Massachusetts.

Recent Trading Activity for athenahealth, Inc (NASDAQ:ATHN)
Shares of athenahealth, Inc closed the previous trading session at 132,45 −0,25 0,19 % with 132.16 shares trading hands.